Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: results of a 104-week extension to a 52-week randomised, phase 3 study and liver fat MRI sub-study

Frías JP, Maaske J, Suchower L, Johansson L, Hockings PD, Iqbal N, Wilding JPH


Diabetes Obes Metab . 2021 Sep 13. doi: 10.1111/dom.14548. Online ahead of print.

View abstract Share on Linkedin Share on Twitter